Proactive Investors - Run By Investors For Investors

Concepta PLC making progress after steep learning curve in China

Erik Henau, Concepta PLC’s (LON:CPT) chief executive, believes a more measured approach to its entry into the Chinese market will make progress smoother in future.

Henau says it is been a steep learning curve in China, but the company has made major strides forward.

More staff have been appointed in the country, while new operating procedures have led to ‘huge improvements’ in manufacturing and logistics.

In Europe, the CE process for its urine-based fertility test is progressing and Concepta has started to gently market its MyLotus product in the UK in anticipation of approval in the summer.

Meet Faron Pharmaceuticals Ltd, Belvoir Lettings, Silence Therapeutics PLC, ANGLE PLC and ReNeuron Group PLC at our event, London , 23 May 2019. Register here »
View full CPT profile View Profile

Concepta Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use